Medtronic transcatheter mitral valve replacement

EuroIntervention

Volumn 10, Issue , 2014, Pages U112-U114

  Piazza, Nicolo ^a,b   Bolling, Steve ^c   Moat, Neil ^d   Treede, Hendrick ^e  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL;

ARTICLE; CORONARY HEMODYNAMICS; ECHOCARDIOGRAPHY; EQUIPMENT DESIGN; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; MINIMALLY INVASIVE PROCEDURE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NONHUMAN; SELF EXPANDING NITINOL STENT; SURGICAL APPROACH; ANIMAL; ENDOVASCULAR SURGERY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY;

ANIMALS; ENDOVASCULAR PROCEDURES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY;

EID: 84907554119     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10SUA16     Document Type: Article

References (12)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-11.
2. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol. 2003;91:360-2.
3. Enriquez-Sarano M, Sundt TM 3rd. Early surgery is recommended for mitral regurgitation. Circulation. 2010;121:804-11.
4. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382-94.
5. Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, Simioniuc A, Gullace M, Ghio S, Enriquez-Sarano M, Temporelli PL. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97:1675-80.
6. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-43.
7. Bach DS, Awais M, Gurm HS, Kohnstamm S. Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol. 2009;54:860-5.
8. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358-65.
9. United Nations. Department of Economic and Social Affairs, Population Division (2011). World population prospects: the 2010 revision.
10. Mehta RH, Eagle KA, Coombs LP, Peterson ED, Edwards FH, Pagani FD, Deeb GM, Bolling SF, Prager RL; Society of Thoracic Surgeons National Cardiac Registry. Influence of age on outcomes in patients undergoing mitral valve replacement. Ann Thorac Surg. 2002;74:1459-67.
11. Goel SS, Bajaj N, Aggarwal B, Gupta S, Poddar KL, Ige M, Bdair H, Anabtawi A, Rahim S, Whitlow PL, Tuzcu EM, Griffin BP, Stewart WJ, Gillinov M, Blackstone EH, Smedira NG, Oliveira GH, Barzilai B, Menon V, Kapadia SR. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014;63:185-6.
12. Chiam PT, Ruiz CE. Percutaneous transcatheter mitral valve repair: a classification of the technology. JACC Cardiovasc Interv. 2011;4:1-13.